Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older
- People who are willing and able to give their formal agreement to take part in the study
- People who can read and understand written and spoken English well enough to understand the study materials and give informed consent
- Women who are not pregnant and are in good general health
- Pregnant women who have a healthy pregnancy
- Pregnant women who have been diagnosed with pre-eclampsia, a condition involving high blood pressure and protein in the urine during pregnancy
- Pregnant women who have been diagnosed with gestational diabetes, a form of diabetes that develops during pregnancy
- Pregnant women whose baby has been diagnosed with restricted growth in the womb
- Pregnant women who have factors that put them at higher risk of pre-eclampsia, such as type 1 or type 2 diabetes, certain autoimmune conditions, or a multiple pregnancy (such as twins or triplets)
Who may not be able to join:
- Women who are not pregnant and have ongoing health conditions that could affect the study results
- Pregnant women who have health conditions unrelated to pre-eclampsia, gestational diabetes, or restricted fetal growth that could affect what the study is measuring — for example, active infections or cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +441865 221009
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Enhanced understanding of the molecular and cellular mechanisms linking placental EVs to maternal systemic inflammation in PET and GDM.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.